RadNet (RDNT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $68.80, -2.29% vs the prior close of $70.41.
- Volume 385.88K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RDNT dips 2.3% to $68.80. Closed at $68.80, -2.29% vs the prior close of $70.41. Day range $68.51β$70.43, opened at $70.41.
RDNT daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β RDNT dips 2.3% to $68.80
- Closed at $68.80, -2.29% vs the prior close of $70.41. Day range $68.51β$70.43, opened at $70.41.
- Volume was 385.88K shares, 0.6x its 50-day average of 692.61K β lighter than usual.
- Price is -6.4% vs its 50-day average ($73.50) and +5.3% vs its 200-day average ($65.34).
- 52-week range $50.82β$85.84; today's close sits at 51% of that range, 19.9% below the 52-week high.
Oct 15, 2026 β RDNT rises 1.8% to $70.41
- Closed at $70.41, +1.81% vs the prior close of $69.16. Day range $69.07β$70.82, opened at $70.12.
- Volume was 461.20K shares, 0.7x its 50-day average of 695.50K.
- Price is -4.2% vs its 50-day average ($73.48) and +7.7% vs its 200-day average ($65.35).
- 52-week range $50.82β$85.84; today's close sits at 56% of that range, 18.0% below the 52-week high.
Oct 14, 2026 β RDNT slides 3.3% to $69.16
- Closed at $69.16, -3.29% vs the prior close of $71.51. Day range $69.02β$71.90, opened at $70.65.
- Volume was 477.70K shares, 0.7x its 50-day average of 718.72K.
- Price is -5.8% vs its 50-day average ($73.42) and +5.8% vs its 200-day average ($65.36).
- 52-week range $50.82β$85.84; today's close sits at 52% of that range, 19.4% below the 52-week high.
Oct 13, 2026 β RDNT ends flat (+0.0%) to $71.51, 3 up days in a row
- Closed at $71.51, +0.03% vs the prior close of $71.49. Day range $70.00β$72.15, opened at $70.81.
- Volume was 478.00K shares, 0.7x its 50-day average of 724.98K.
- Price is -2.6% vs its 50-day average ($73.42) and +9.4% vs its 200-day average ($65.38).
- 52-week range $50.82β$85.84; today's close sits at 59% of that range, 16.7% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 β RDNT rises 0.8% to $71.49
- Closed at $71.49, +0.82% vs the prior close of $70.91. Day range $70.11β$71.78, opened at $70.88.
- Volume was 383.40K shares, 0.5x its 50-day average of 729.24K β lighter than usual.
- Price is -2.5% vs its 50-day average ($73.32) and +9.3% vs its 200-day average ($65.39).
- 52-week range $50.82β$85.84; today's close sits at 59% of that range, 16.7% below the 52-week high.
Oct 9, 2026 β RDNT jumps 4.0% to $70.91
- Closed at $70.91, +3.96% vs the prior close of $68.21. Day range $68.13β$71.11, opened at $68.41.
- Volume was 507.40K shares, 0.7x its 50-day average of 729.58K.
- Price is -3.1% vs its 50-day average ($73.17) and +8.4% vs its 200-day average ($65.40).
- 52-week range $50.82β$85.84; today's close sits at 57% of that range, 17.4% below the 52-week high.
Oct 8, 2026 β RDNT dips 0.6% to $68.21, 3 down days in a row
- Closed at $68.21, -0.58% vs the prior close of $68.61. Day range $66.23β$68.50, opened at $68.16.
- Volume was 722.30K shares, 1.0x its 50-day average of 732.46K.
- Price is -6.6% vs its 50-day average ($73.00) and +4.3% vs its 200-day average ($65.42).
- 52-week range $50.82β$85.84; today's close sits at 50% of that range, 20.5% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 β RDNT dips 2.4% to $68.61
- Closed at $68.61, -2.38% vs the prior close of $70.28. Day range $68.45β$70.66, opened at $69.57.
- Volume was 398.60K shares, 0.5x its 50-day average of 743.06K β lighter than usual.
- Price is -5.9% vs its 50-day average ($72.91) and +4.8% vs its 200-day average ($65.46).
- 52-week range $50.82β$85.84; today's close sits at 51% of that range, 20.1% below the 52-week high.
Oct 6, 2026 β RDNT dips 0.4% to $70.28
- Closed at $70.28, -0.41% vs the prior close of $70.57. Day range $69.44β$71.54, opened at $71.27.
- Volume was 291.70K shares, 0.4x its 50-day average of 746.76K β lighter than usual.
- Price is -3.5% vs its 50-day average ($72.80) and +7.3% vs its 200-day average ($65.47).
- 52-week range $50.82β$85.84; today's close sits at 56% of that range, 18.1% below the 52-week high.
Oct 5, 2026 β RDNT rises 0.9% to $70.57
- Closed at $70.57, +0.92% vs the prior close of $69.93. Day range $69.40β$71.86, opened at $69.87.
- Volume was 681.40K shares, 0.9x its 50-day average of 745.23K.
- Price is -2.8% vs its 50-day average ($72.62) and +7.8% vs its 200-day average ($65.48).
- 52-week range $50.82β$85.84; today's close sits at 56% of that range, 17.8% below the 52-week high.
Oct 2, 2026 β RDNT jumps 3.3% to $69.93
- Closed at $69.93, +3.29% vs the prior close of $67.70. Day range $67.80β$70.68, opened at $68.52.
- Volume was 574.20K shares, 0.8x its 50-day average of 742.93K.
- Price is -3.5% vs its 50-day average ($72.44) and +6.8% vs its 200-day average ($65.48).
- 52-week range $50.82β$85.84; today's close sits at 55% of that range, 18.5% below the 52-week high.
RDNT latest news & SEC filings
Every SEC filing by or about RDNT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Aug 14, 2026 Β· Form 424B7 β Prospectus supplement for a resale by holders
Prospectus supplement for a resale by holders
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $622.72M (prior year $498.23M) (+25.0% vs Jun 30, 2025)
- Net income: $7.53M (prior year $14.45M) (-47.9% vs Jun 30, 2025)
- Diluted EPS: $0.10 (prior year $0.19) (-47.4% vs Jun 30, 2025)
Aug 10, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 22, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Swartz David L sold 2,699 shares at $53.89 (β$145.45K) on Jun 18, 2026
- Swartz David L sold 2,699 shares at $53.89 (β$145.45K) on Jun 18, 2026
- Swartz David L sold 2,699 shares at $53.89 (β$145.45K) on Jun 18, 2026
- Swartz David L sold 2,699 shares at $53.89 (β$145.45K) on Jun 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade RDNT
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 2, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.87% (largest 4.4%).
- Liquidity: about 572.30K shares (β$39.37M) trade per day on average.
- 52-week position: $68.80 vs a range of $50.82β$85.84 (51% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: David L Swartz sold 2,699 shares on Jun 18, 2026.
- Latest filings: 8-K Aug 14, 2026; 10-Q Aug 10, 2026; 8-K Aug 10, 2026.
- Share count: 78.70M shares outstanding (Aug 6, 2026), +2.3% vs a year earlier.
- Listing: Nasdaq Β· industry: Services-Medical Laboratories.
RDNT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 70.41 | 70.43 | 68.51 | 68.80 | 385.88K |
| Oct 15, 2026 | 70.12 | 70.82 | 69.07 | 70.41 | 461.20K |
| Oct 14, 2026 | 70.65 | 71.90 | 69.02 | 69.16 | 477.70K |
| Oct 13, 2026 | 70.81 | 72.15 | 70.00 | 71.51 | 478.00K |
| Oct 12, 2026 | 70.88 | 71.78 | 70.11 | 71.49 | 383.40K |
| Oct 9, 2026 | 68.41 | 71.11 | 68.13 | 70.91 | 507.40K |
| Oct 8, 2026 | 68.16 | 68.50 | 66.23 | 68.21 | 722.30K |
| Oct 7, 2026 | 69.57 | 70.66 | 68.45 | 68.61 | 398.60K |
| Oct 6, 2026 | 71.27 | 71.54 | 69.44 | 70.28 | 291.70K |
| Oct 5, 2026 | 69.87 | 71.86 | 69.40 | 70.57 | 681.40K |
| Oct 2, 2026 | 68.52 | 70.68 | 67.80 | 69.93 | 574.20K |
| Oct 1, 2026 | 68.80 | 69.70 | 67.32 | 67.70 | 928.70K |
| Sep 30, 2026 | 70.22 | 70.85 | 68.94 | 68.94 | 621.20K |
| Sep 29, 2026 | 71.92 | 72.58 | 69.49 | 70.65 | 501.00K |
| Sep 28, 2026 | 70.08 | 72.84 | 69.62 | 71.81 | 528.20K |
| Sep 25, 2026 | 70.81 | 71.48 | 69.58 | 70.79 | 598.70K |
| Sep 24, 2026 | 73.11 | 73.70 | 70.96 | 71.31 | 754.10K |
| Sep 23, 2026 | 73.61 | 74.35 | 72.68 | 73.21 | 560.70K |
| Sep 22, 2026 | 73.71 | 74.81 | 73.01 | 73.93 | 795.40K |
| Sep 21, 2026 | 76.27 | 76.45 | 72.62 | 72.67 | 796.20K |
About RadNet
RadNet (RDNT) is listed on the Nasdaq and classified by the SEC under βServices-Medical Laboratoriesβ. Its business address is in LOS ANGELES, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 790526.
RDNT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Howard G Berger | President, CEO | Jun 18, 2026 |
| Laura Pastre Jacobs | Director | Jun 3, 2026 |
| Lawrence L Levitt | Director | Jun 3, 2026 |
| Gregory E. Spurlock | Director | Jun 3, 2026 |
| David L Swartz | Director | Jun 22, 2026 |
| Alma Gregory Sorensen | Chief Strategy Officer | Mar 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Howard G Berger | President, CEO | Jun 18, 2026 |
| Stephen M Forthuber | Pres & CEO-Eastern Operations | Jun 16, 2026 |
| Norman R Hames | Pres and COO-West Operations | Mar 5, 2026 |
| David Jeffrey Katz | EVP and Chief Legal Officer | Mar 5, 2026 |
| Michael N Murdock | EVP, Mergers and Acquisitions | Mar 5, 2026 |
| Mital Patel | EVP of Fin Planning, CAO | Mar 5, 2026 |
| Mark Stolper | EVP, Chief Financial Officer | Mar 5, 2026 |
| Alma Gregory Sorensen | Chief Strategy Officer | Mar 23, 2026 |
| Cornelis Wesdorp | Pres & CEO, Digital Health | Jun 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 18, 2026 | David L Swartz | Sale | 2,699 | $53.89 |
| Jun 18, 2026 | David L Swartz | Sale | 2,699 | $53.89 |
| Jun 18, 2026 | David L Swartz | Sale | 2,699 | $53.89 |
| Jun 18, 2026 | David L Swartz | Sale | 2,699 | $53.89 |
| Jun 16, 2026 | Cornelis Wesdorp | Sale | 4,750 | $58.11 |
| Jun 16, 2026 | Cornelis Wesdorp | Sale | 4,750 | $58.11 |
| Jun 16, 2026 | Cornelis Wesdorp | Sale | 4,750 | $58.11 |
| Jun 16, 2026 | Cornelis Wesdorp | Sale | 4,750 | $58.11 |
| Jun 15, 2026 | Stephen M Forthuber | Sale | 19,853 | $58.61 |
| Jun 15, 2026 | Stephen M Forthuber | Sale | 24,214 | $57.79 |
| Jun 15, 2026 | Stephen M Forthuber | Sale | 19,853 | $58.61 |
| Jun 15, 2026 | Stephen M Forthuber | Sale | 24,214 | $57.79 |
| Jun 15, 2026 | Stephen M Forthuber | Sale | 19,853 | $58.61 |
| Jun 15, 2026 | Stephen M Forthuber | Sale | 24,214 | $57.79 |
| Jun 15, 2026 | Stephen M Forthuber | Sale | 19,853 | $58.61 |
RDNT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.04B | $-18.65M | -0.25 | $298.82M |
| Dec 31, 2024 | $1.83B | $2.79M | 0.04 | $233.02M |
| Dec 31, 2023 | $1.62B | $3.04M | 0.05 | $220.86M |
| Dec 31, 2022 | $1.43B | $10.65M | 0.17 | $146.42M |
| Dec 31, 2021 | $1.32B | $24.73M | 0.46 | $149.49M |
Latest balance sheet: total assets $4.23B, total liabilities $2.83B, cash $726.27M (as of Jun 30, 2026).
RDNT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $77.28 |
| May 11, 2026 | 8-K Item 2.02 (results) | $55.90 |
| Mar 2, 2026 | 8-K Item 2.02 (results) | $75.22 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $80.85 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $62.00 |
| May 12, 2025 | 8-K Item 2.02 (results) | $57.03 |
| Mar 5, 2025 | 8-K Item 2.02 (results) | $53.09 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $83.59 |
| Aug 9, 2024 | 8-K Item 2.02 (results) | β |
| May 13, 2024 | 8-K Item 2.02 (results) | β |
| Mar 5, 2024 | 8-K Item 2.02 (results) | β |
| Nov 13, 2023 | 8-K Item 2.02 (results) | β |
Related stocks Β· Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on RDNT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.